A detailed history of True Wealth Design, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, True Wealth Design, LLC holds 699 shares of EXEL stock, worth $23,786. This represents 0.01% of its overall portfolio holdings.

Number of Shares
699
Previous 36,865 98.1%
Holding current value
$23,786
Previous $828 Million 97.81%
% of portfolio
0.01%
Previous 0.2%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.96 - $27.6 $794,205 - $998,181
-36,166 Reduced 98.1%
699 $18.1 Million
Q2 2024

Aug 14, 2024

BUY
$20.34 - $23.73 $29,187 - $34,052
1,435 Added 4.05%
36,865 $828 Million
Q1 2024

May 14, 2024

BUY
$20.17 - $23.93 $18,435 - $21,872
914 Added 2.65%
35,430 $841 Million
Q4 2023

Feb 14, 2024

BUY
$19.25 - $24.13 $664,433 - $832,871
34,516 New
34,516 $828 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.